Ant Group Unveils its Financial Large Language Model and Two New Applications
Ant Group today unveiled its financial large language model (“the financial LLM”) at the 2023 INCLUSION·Conference on the Bund, alongside two new applications powered by the financial LLM including Zhixiaobao 2.0, an intelligent financial assistant for consumers, and Zhixiaozhu 1.0, an intelligent business assistant serving financial industry professionals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230908406520/en/
Wang Xiaohang, Vice President of Ant Group and head of financial LLM, at the 2023 INCLUSION·Conference on the Bund (Photo: Business Wire)
According to Fin-Eval, Ant Group’s in-house benchmark developed to measure the performance of AI in finance, the company’s financial LLM outperforms general-purpose LLMs across 5 key areas, including cognition, generation, domain knowledge, professional thinking, and compliance. In Fin-Eval’s 28 financial-specific task categories, Ant Group’s financial LLM also outperformed industry average in tests such as insights extraction on researches and analysis, understanding of financial intentions and reasoning on financial events.
To achieve this performance, Ant Group’s financial LLM is trained on over hundreds of billions of token datasets containing Chinese financial documents, in addition to over 1,000 billion tokens from general corpus datasets. Furthermore, the financial LLM also utilizes a dataset of more than 600,000 instructions from over 300 real-world industry use cases, significantly optimizing its capability for financial-specific tasks.
The financial LLM was fine-tuned based on Ant Group's self-developed general-purpose LLM which features high efficiency in computing power use. For example, Ant Group’s general-purpose model utilizes a heterogeneous hardware cluster, which supports up to ten thousand GPUs of different kinds, with its model FLOPs utilization (MFU) for a thousand GPUs reaching 40%. Moreover, the model’s Reinforcement Learning from Human Feedback (RLHF) training throughput under consistent model performance is enhanced by a factor of 3.59 and inference performance is improved by approximately 2 times compared to the existing industry benchmark.
With its technical capability, the financial LLM is able to power a wide range of professional services, encompassing wealth management such as financial product evaluation, market analysis, and investor education, as well as insurance services such as explaining insurance products, making family insurance plans, and verifying insurance claims.
"General-purpose LLMs are difficult to be applied to industry specific use. To truly bring value to the finance industry, language capabilities, domain knowledge, domain expertise and security capabilities are the prerequisite conditions, which are also key challenges to the development of financial LLMs," said Wang Xiaohang, Vice President of Ant Group and head of financial LLM. "Based on our extensive experiences from financial service businesses, Ant Group has developed an architecture integrating LLM technologies with domain knowledges and industry services, which has already been tested in Ant Groups' intelligent financial services scenarios."
Looking ahead, Ant Group will leverage the power of its financial LLM across all digital financial services in collaboration with institutions in China market.
On the same day, Ant Group also open sourced its AI-powered coding platform CodeFuse for the developer community. The company also made its financial-specific AI task benchmark Fin-Eval available to the public to facilitate industrial innovation of LLM for the financial industry.
Two new applications: Zhixiaobao 2.0 and Zhixiaozhu 1.0
Ant Group’s financial LLM is now in closed tests on its wealth management and insurance platforms, and has been integrated into its various intelligent services.
With the help of LLM technology, the intelligent financial assistant Zhixiaobao 2.0 can provide high quality services to consumers, including market analysis, portfolio diagnosis, asset allocation suggestions, and investors education. It has achieved a 95% accuracy rate in financial intention recognition, with a capability of market analysis and reasoning reaching the averages of professionals, and can engage in high-quality multi-round conversations.
Meanwhile, the intelligent business assistant, Zhixiaozhu 1.0, can be tailored to help various financial professionals such as service representatives, investment advisors and insurance claim specialists, offering comprehensive and intelligent support for tasks such as investment analysis, information extraction, content creation, business opportunity insights, and financial tool utilization.
So far, Zhixiaobao 2.0 has been in closed test for about six months and will be available to users after it receives regulatory approval. Zhixiaozhu 1.0 is currently undergoing additional closed tests by Ant Group and industry partners on the company’s financial platforms.
Ant Group started the financial LLM project at the end of 2022. To better support the development of inclusive financial services, Ant Group is exploring a set of comprehensive AI technologies including knowledge graph, operations optimization, graph learning, trustworthy AI, and LLM.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses21.9.2023 17:00:00 EEST | Press release
Altasciences is pleased to have been chosen by Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) (“Virpax”), a company specializing in developing non-addictive products for pain management, PTSD, central nervous system (CNS) disorders, and viral barrier indications, to conduct preclinical studies in support of their development of quaternary ammonium palmitoyl glycol chitosan (GCPQ, under the trade name of AnQlar™). AnQlar is a nanoparticle intended to help prevent the spread of negatively charged viruses such as COVID-19 and influenza via intranasal spray, and has shown to inhibit the ability of the virus to replicate at non-toxic concentrations. In development since 2022, the project has so far seen the completion of safety assessment utilizing intranasal administration at Altasciences’ preclinical site in Columbia, MO. A cardiovascular study was also completed at Altasciences’ preclinical facility in Scranton, PA. Bioanalytical sample analysis for the GLP studies is currently ongoing. “We
Nitek: End of the Road for Copycats21.9.2023 16:00:00 EEST | Press release
Nitek, Inc. (“Nitek”), a pioneering American company in UV LEDs, has announced that it filed a patent infringement lawsuit against Photon Wave Co., Ltd. (“Photon Wave”), a Korean UV LED manufacturer in the Eastern District of Texas. In the complaint, Nitek asserts that LED products of ams OSRAM, a German LED company, use Photon Wave’s infringing LEDs. Nitek also contends that Photon Wave has failed to cease selling infringing products, even after getting continuous warning notices of the patent infringement, and therefore Nitek is not only seeking a permanent injunction against the sales of infringing products but also pursuing 3 times damages for willful patent infringement. Nitek has previously successfully won its patent lawsuit against another international LED maker, and continues its enforcement against other infringers. Sensor Electronic Technology, Inc. (“SETi”), an affiliate of Nitek, has also obtained a permanent injunction for patent infringement against Bolb, Inc., a UV LED
Boomi Launches World Tour, Bringing Together Visionary Leaders and Industry Experts to Prepare Businesses for the AI Revolution21.9.2023 16:00:00 EEST | Press release
Boomi™, the intelligent connectivity and automation leader, today announced the Boomi World Tour, a premiere series of exclusive, in-person events bringing together Boomi customers, prospects, and partners to hear directly from Boomi leadership, industry experts, and visionaries on how organizations can leave complexity behind and synchronize everything, everywhere, with AI-driven integration and automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230921479137/en/ Boomi Launches World Tour, Bringing Together Visionary Leaders and Industry Experts to Prepare Businesses for the AI Revolution (Graphic: Business Wire) The Boomi World Tour is a series of 10 events over eight weeks, including three Partner Summits designed especially for Boomi partners, global systems integrators, and OEMs. The tour kicks off in Menlo Park, CA, October 3-4, 2023, where attendees will have opportunities to connect and learn throughout the tw
Hologic and Bayer Announce International Partnership to Deliver Comprehensive Contrast-Enhanced Mammography Package to Breast Imaging Facilities21.9.2023 15:30:00 EEST | Press release
Hologic Inc. (Nasdaq: HOLX) and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries across the European, Canadian and Asia Pacific regions. CEM is a highly sensitive and relatively low-cost breast imaging modality that combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.1 The partnership brings together the companies’ leading technologies (Hologic mammography gantries and Bayer CEM-approved injection systems) to enable the administration of contrast media during a mammography examination. With the new agreement, Bayer and Hologic aim to optimally support radiologists and their teams’ needs by providing a comprehensive product package along with the hands-on training needed to effectively implement CEM into their facility’s workflow. “Over the past several years, we’ve seen
ReNAgade Therapeutics Named to the 2023 Endpoints 1121.9.2023 15:00:00 EEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that it has been named as one of the Endpoints 11 companies of 2023, awarded by Endpoints News editor John Carroll to the most promising private biotechnology companies in the industry. “To be included as one of the Endpoints 11 top private biotech companies is not only a great honor for our young company, but also recognition from the industry of what we’ve already accomplished in the past 18 months toward our aim of overcoming the current limitations of RNA medicines,” said Amit D. Munshi, Chief Executive Officer of ReNAgade. “The Company has continued to grow since our $300 million Series A financing round, building on our world-class, multidisciplinary team that is dedicated to innovating delivery technology and bringing an array of genomic medicine tools under one roof. We look forward to expanding the reach of RNA medicine beyond what was previously thought possible, beginning wi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom